17
May 2026
Time in nature may improve disadvantaged children’s mental health
Growing up in disadvantaged communities can take a toll on children, with greater stress leading to mental health issues and delays in psychological development.

Increasing and changing demands concerning the health of populations and limited resources require our health care organizations and systems to rethink their sustainability. To achieve objectives, such as improved healthcare quality, health outcomes, efficiency and staff satisfaction, we support our clients in making evidence-based decisions. With tailor-made research projects, we provide insights into what works, for whom, at what cost, and under what circumstances. Based on your challenge, we can support you by:
Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more
Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more
Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more
17
May 2026
Growing up in disadvantaged communities can take a toll on children, with greater stress leading to mental health issues and delays in psychological development.
17
May 2026
Low-risk patients at predominantly Black-serving hospitals (BSH) who previously gave birth through Cesareans are likelier to attempt and successfully deliver vaginally in a subsequent pregnancy than they are at hospitals treating few Black patients, new UCLA-led research finds.
17
May 2026
Treating breast cancer that has begun to spread around the body with targeted radiotherapy could help patients to live longer without their cancer getting worse, according to the results of a small randomised controlled trial presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026).
17
May 2026
Two larger doses of radiotherapy for prostate cancer cause no additional side effects compared to the standard five doses of radiotherapy, according to results presented at the Congress of the European Society for Radiotherapy and Oncology (ESTRO 2026).